Interleukin 22 Monoclonal Antibodies

179 Interleukin 22 monoclonal antibodies from 14 antibody suppliers Click each Interleukin 22 monoclonal antibody that interests you to view the full Interleukin 22 monoclonal antibody datasheet.

Flow Cytometry - Use Filter to switch application

Supplier data
Boster Biological Technology M00963

Interleukin 22 antibody, M00963, Boster Biological Technology. Figure 1. Flow Cytometry analysis of HL-60 cells using anti-IL22 antibody (M00963).<br> Overlay histogram showing HL-60 cells stained with M00963 (Blue line).The cells were blocked with 10% normal goat serum. And then incubated with mouse anti-IL22 Antibody (M00963,1μg/1x10<sup>6</sup> cells) for 30 min at 20°C. DyLight®488 conjugated goat anti-mouse IgG (BA1126, 5-10μg/1x10<sup>6</sup> cells) was used as secondary antibody for 30 minutes at 20°C. Isotype control antibo

Mouse Mono [M00963], 100 ug
Hu
FACS, WB

Interleukin 22 antibody, M00963, Boster Biological Technology, Western Blot image

Supplier data
Boster Biological Technology M00963-Dyl488 Interleukin 22 antibody, M00963-Dyl488, Boster Biological Technology.

Mouse Mono [M00963-Dyl488], 100 ug
Hu
FACS

Supplier data
Boster Biological Technology M00963-Dyl550 Interleukin 22 antibody, M00963-Dyl550, Boster Biological Technology.

Mouse Mono [M00963-Dyl550], 100 ug
Hu
FACS

Supplier data
R&D Systems MAB582 Interleukin 22 antibody, MAB582, R&D Systems. Detection of IL-22 in Mouse Splenocytes by Flow Cytometry.

Rat Mono [140301], 500 ug
Mo
FACS, WB

Interleukin 22 antibody, MAB582, R&D Systems, Western Blot image

Supplier data
BioLegend 366705 Interleukin 22 antibody, 366705, BioLegend. Peripheral blood mononuclear cells were stimulated with PMA + ionomycin (6hrs, in the presence of monensin), stained with CD4 PE, fixed, permeabilized, and intracellularly stained with IL-22 (clone 2G12A41) APC (top) or mouse IgG2a, κ APC isotype control (bottom).

Interleukin 22 antibody, 366705, BioLegend. Peripheral blood mononuclear cells were stimulated with PMA + ionomycin (6hrs, in the presence of monensin), stained with CD4 PE, fixed, permeabilized, and intracellularly stained with IL-22 (clone 2G12A41) APC (top) or mouse IgG2a, κ APC isotype control (bottom).

Mouse Mono [2G12A41], 25 Test
Hu
FACS

Supplier data
BioLegend 366711 Interleukin 22 antibody, 366711, BioLegend. Peripheral blood mononuclear cells were stimulated with PMA + ionomycin (6hrs, in the presence of monensin), stained with CD4 APC, fixed, permeabilized, and intracellularly stained with IL-22 (clone 2G12A41) FITC (top) or mouse IgG2a, κ FITC isotype control (bottom). Data shown was gated on lymphocyte population.

Interleukin 22 antibody, 366711, BioLegend. Peripheral blood mononuclear cells were stimulated with PMA + ionomycin (6hrs, in the presence of monensin), stained with CD4 APC, fixed, permeabilized, and intracellularly stained with IL-22 (clone 2G12A41) FITC (top) or mouse IgG2a, κ FITC isotype control (bottom). Data shown was gated on lymphocyte population.

Mouse Mono [2G12A41], 25 Test
Hu
FACS

Supplier data
BioLegend 366710 Interleukin 22 antibody, 366710, BioLegend. Peripheral blood mononuclear cells were stimulated with PMA + ionomycin (6hrs, in the presence of monensin), stained with CD4 APC, fixed, permeabilized, and intracellularly stained with IL-22 (clone 2G12A41) PerCP/Cy5.5 (top) or mouse IgG2a, κ PerCP/Cy5.5 isotype control (bottom).

Interleukin 22 antibody, 366710, BioLegend. Peripheral blood mononuclear cells were stimulated with PMA + ionomycin (6hrs, in the presence of monensin), stained with CD4 APC, fixed, permeabilized, and intracellularly stained with IL-22 (clone 2G12A41) PerCP/Cy5.5 (top) or mouse IgG2a, κ PerCP/Cy5.5 isotype control (bottom).

Mouse Mono [2G12A41], 100 Test
Hu
FACS

Supplier data
BioLegend 366706 Interleukin 22 antibody, 366706, BioLegend. Peripheral blood mononuclear cells were stimulated with PMA + ionomycin (6hrs, in the presence of monensin), stained with CD4 PE, fixed, permeabilized, and intracellularly stained with IL-22 (clone 2G12A41) APC (top) or mouse IgG2a, κ APC isotype control (bottom).

Interleukin 22 antibody, 366706, BioLegend. Peripheral blood mononuclear cells were stimulated with PMA + ionomycin (6hrs, in the presence of monensin), stained with CD4 PE, fixed, permeabilized, and intracellularly stained with IL-22 (clone 2G12A41) APC (top) or mouse IgG2a, κ APC isotype control (bottom).

Mouse Mono [2G12A41], 100 Test
Hu
FACS

Supplier data
BioLegend 366709 Interleukin 22 antibody, 366709, BioLegend. Peripheral blood mononuclear cells were stimulated with PMA + ionomycin (6hrs, in the presence of monensin), stained with CD4 APC, fixed, permeabilized, and intracellularly stained with IL-22 (clone 2G12A41) PerCP/Cy5.5 (top) or mouse IgG2a, κ PerCP/Cy5.5 isotype control (bottom).

Interleukin 22 antibody, 366709, BioLegend. Peripheral blood mononuclear cells were stimulated with PMA + ionomycin (6hrs, in the presence of monensin), stained with CD4 APC, fixed, permeabilized, and intracellularly stained with IL-22 (clone 2G12A41) PerCP/Cy5.5 (top) or mouse IgG2a, κ PerCP/Cy5.5 isotype control (bottom).

Mouse Mono [2G12A41], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 11-7229-41

Interleukin 22 antibody, 11-7229-41, Invitrogen Antibodies. Intracellular staining of CD4-enriched Th17-polarized (using Human IL-23 Recombinant Protein (Product # 14-8239-63), normal human peripheral blood cells with Anti-Human CD4 eFluor® 450 (Product # 48-0049-42) and Anti-Human IL-22 FITC. Cultures were treated with Protein Transport Inhibitor Cocktail (500X) (Product # 00-4980-03) alone (left) or Cell Stimulation Cocktail (plus protein transport inhibitors) (500X) (Product # 00-4975-03) (right) for 5 hours prior to intracellular staining using t

Mouse Mono [22URTI], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 46-7222-80

Interleukin 22 antibody, 46-7222-80, Invitrogen Antibodies. Th17 polarized mouse splenocytes either unstimulated (left) or stimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (500X) (right) were intracellularly stained with Anti-Mouse CD4 FITC (Product # 11-0042-82) and 0.125 µg of Anti-Human/Mouse IL-22 PerCP-eFluor® 710. Cells in the lymphocyte gate were used for analysis.

Rat Mono [IL22JOP], 25 ug
Hu, Mo, Pr
FACS

Supplier data
Invitrogen Antibodies 46-7229-42

Interleukin 22 antibody, 46-7229-42, Invitrogen Antibodies. Intracellular staining of Th17-polarized normal human peripheral blood cells treated with Brefeldin A (Product # 00-4506-51) (left) or restimulated with PMA/Ionomycin in the presence of Brefeldin A (right) with Anti-Human IL-17F PE (Product # 12-7169-42) and Anti-Human IL-22 PerCP-eFluor® 710. Cells in the lymphocyte gate were used for analysis.

Mouse Mono [22URTI], 100 Test
Hu
FACS

Show/hide more from BioLegend

Supplier data
BioLegend 366708 Interleukin 22 antibody, 366708, BioLegend. PMA + ionomycin stimulated (6 hours, in the presence of monensin) stimulated PBMCs were stained with CD4 APC, fixed, permeabilized, and intracellularly stained with IL-22 (clone 2G12A41) PE/Cy7 (top) or mouse IgG2a, κ PE/Cy7 isotype control (bottom).

Interleukin 22 antibody, 366708, BioLegend. PMA + ionomycin stimulated (6 hours, in the presence of monensin) stimulated PBMCs were stained with CD4 APC, fixed, permeabilized, and intracellularly stained with IL-22 (clone 2G12A41) PE/Cy7 (top) or mouse IgG2a, κ PE/Cy7 isotype control (bottom).

Mouse Mono [2G12A41], 100 Test
Hu
FACS

Supplier data
BioLegend 366713 Interleukin 22 antibody, 366713, BioLegend. PMA and ionomycin (5 hours in the presence of Brefeldin A) stimulated human peripheral blood mononuclear cells were stained with CD4 FITC, fixed, permeabilized, and stained with APC/Fire™ 750 mouse IgG2a, κ isotype control (right), or APC/Fire™ 750 IL-22 (clone 2G12A41, left).

Interleukin 22 antibody, 366713, BioLegend. PMA and ionomycin (5 hours in the presence of Brefeldin A) stimulated human peripheral blood mononuclear cells were stained with CD4 FITC, fixed, permeabilized, and stained with APC/Fire™ 750 mouse IgG2a, κ isotype control (right), or APC/Fire™ 750 IL-22 (clone 2G12A41, left).

Mouse Mono [2G12A41], 25 Test
Hu
FACS

Supplier data
BioLegend 366707 Interleukin 22 antibody, 366707, BioLegend. PMA + ionomycin stimulated (6 hours, in the presence of monensin) stimulated PBMCs were stained with CD4 APC, fixed, permeabilized, and intracellularly stained with IL-22 (clone 2G12A41) PE/Cy7 (top) or mouse IgG2a, κ PE/Cy7 isotype control (bottom).

Interleukin 22 antibody, 366707, BioLegend. PMA + ionomycin stimulated (6 hours, in the presence of monensin) stimulated PBMCs were stained with CD4 APC, fixed, permeabilized, and intracellularly stained with IL-22 (clone 2G12A41) PE/Cy7 (top) or mouse IgG2a, κ PE/Cy7 isotype control (bottom).

Mouse Mono [2G12A41], 25 Test
Hu
FACS

Supplier data
BioLegend 366712 Interleukin 22 antibody, 366712, BioLegend. Peripheral blood mononuclear cells were stimulated with PMA + ionomycin (6hrs, in the presence of monensin), stained with CD4 APC, fixed, permeabilized, and intracellularly stained with IL-22 (clone 2G12A41) FITC (top) or mouse IgG2a, κ FITC isotype control (bottom). Data shown was gated on lymphocyte population.

Interleukin 22 antibody, 366712, BioLegend. Peripheral blood mononuclear cells were stimulated with PMA + ionomycin (6hrs, in the presence of monensin), stained with CD4 APC, fixed, permeabilized, and intracellularly stained with IL-22 (clone 2G12A41) FITC (top) or mouse IgG2a, κ FITC isotype control (bottom). Data shown was gated on lymphocyte population.

Mouse Mono [2G12A41], 100 Test
Hu
FACS

Supplier data
BioLegend 366714 Interleukin 22 antibody, 366714, BioLegend. PMA and ionomycin (5 hours in the presence of Brefeldin A) stimulated human peripheral blood mononuclear cells were stained with CD4 FITC, fixed, permeabilized, and stained with APC/Fire™ 750 mouse IgG2a, κ isotype control (right), or APC/Fire™ 750 IL-22 (clone 2G12A41, left).

Interleukin 22 antibody, 366714, BioLegend. PMA and ionomycin (5 hours in the presence of Brefeldin A) stimulated human peripheral blood mononuclear cells were stained with CD4 FITC, fixed, permeabilized, and stained with APC/Fire™ 750 mouse IgG2a, κ isotype control (right), or APC/Fire™ 750 IL-22 (clone 2G12A41, left).

Mouse Mono [2G12A41], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 46-7222-82

Interleukin 22 antibody, 46-7222-82, Invitrogen Antibodies. Th17 polarized mouse splenocytes either unstimulated (left) or stimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (500X) (right) were intracellularly stained with Anti-Mouse CD4 FITC (Product # 11-0042-82) and 0.125 µg of Anti-Human/Mouse IL-22 PerCP-eFluor® 710. Cells in the lymphocyte gate were used for analysis.

Rat Mono [IL22JOP], 100 ug
Hu, Mo, Pr
FACS

Supplier data
Invitrogen Antibodies 46-7221-80

Interleukin 22 antibody, 46-7221-80, Invitrogen Antibodies. Intracellular staining of 10-day Th17-polarized mouse splenocytes treated with Brefeldin A (Product # 00-4506-51) (left) or restimulated with PMA/Ionomycin in the presence of Brefeldin A for 5 hours (right) with Anti-Mouse CD4 FITC (Product # 11-0042-82) and 0.06 µg of Anti-Mouse IL-22 PerCP-eFluor® 710. Cells in the lymphocyte gate were used for analysis.

Rat Mono [1H8PWSR], 25 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 12-7229-42

Interleukin 22 antibody, 12-7229-42, Invitrogen Antibodies. Intracellular staining of CD4-enriched Th17-polarized (using Human IL-23 Recombinant Protein (Product # 14-8239-63), normal human peripheral blood cells with Anti-Human CD4 FITC (Product # 11-0049-42) and Anti-Human IL-22 PE. Cultures were treated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) alone (Product # 00-4506-51) Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right) for 5 hours prior to intracellular staining using the Intr

Mouse Mono [22URTI], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 50-7229-42

Interleukin 22 antibody, 50-7229-42, Invitrogen Antibodies. CD4-enriched human peripheral blood cells were polarized under Th17 conditions (with Human IL-23 Recombinant Protein (Product # 14-8239-63) for 10 days. Cells were restimulated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) or Cell Stimulation Cocktail plus Protein Transport Inhibitors (Product # 00-4975-03) (right) for 6 hours. Cells were intracellularly stained with Anti-Human CD4 PE (Product # 12-0047-42) and Anti-Human IL-22 eFluor® 660 using the Intracellular Fi

Mouse Mono [22URTI], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 25-7229-42

Interleukin 22 antibody, 25-7229-42, Invitrogen Antibodies. Intracellular staining of CD4-enriched Th17-polarized (using Human IL-23 Recombinant Protein (Product # 14-8239-63), normal human peripheral blood cells with Anti-Human CD4 FITC (Product # 11-0049-42) and Anti-Human IL-22 PE-Cyanine7. Cultures were treated with Protein Transport Inhibitor Cocktail alone (Product # 00-4980-03) (left) or Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right) for 5 hours prior to intracellular staining using the Intracellular F

Mouse Mono [22URTI], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 12-7221-80

Interleukin 22 antibody, 12-7221-80, Invitrogen Antibodies. Staining of 11-day Th17-polarized mouse splenocytes with Anti-Mouse CD4 FITC (Product # 11-0042-82) and 0.06 µg of Anti-Mouse IL-22 PE. Cells were treated with Brefeldin A (Product # 00-4506-51) alone (left) or PMA, Ionomycin, and Brefeldin A (right) for 5 hours prior to intracellular staining. Cells in the lymphocyte gate were used for analysis.

Rat Mono [1H8PWSR], 25 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 46-7221-82

Interleukin 22 antibody, 46-7221-82, Invitrogen Antibodies. Intracellular staining of 10-day Th17-polarized mouse splenocytes treated with Brefeldin A (Product # 00-4506-51) (left) or restimulated with PMA/Ionomycin in the presence of Brefeldin A for 5 hours (right) with Anti-Mouse CD4 FITC (Product # 11-0042-82) and 0.06 µg of Anti-Mouse IL-22 PerCP-eFluor® 710. Cells in the lymphocyte gate were used for analysis.

Rat Mono [1H8PWSR], 100 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 12-7229-41

Interleukin 22 antibody, 12-7229-41, Invitrogen Antibodies. Intracellular staining of CD4-enriched Th17-polarized (using Human IL-23 Recombinant Protein (Product # 14-8239-63), normal human peripheral blood cells with Anti-Human CD4 FITC (Product # 11-0049-42) and Anti-Human IL-22 PE. Cultures were treated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) alone (Product # 00-4506-51) Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right) for 5 hours prior to intracellular staining using the Intr

Mouse Mono [22URTI], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 50-7229-41

Interleukin 22 antibody, 50-7229-41, Invitrogen Antibodies. CD4-enriched human peripheral blood cells were polarized under Th17 conditions (with Human IL-23 Recombinant Protein (Product # 14-8239-63) for 10 days. Cells were restimulated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) or Cell Stimulation Cocktail plus Protein Transport Inhibitors (Product # 00-4975-03) (right) for 6 hours. Cells were intracellularly stained with Anti-Human CD4 PE (Product # 12-0047-42) and Anti-Human IL-22 eFluor® 660 using the Intracellular Fi

Mouse Mono [22URTI], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 17-7222-80

Interleukin 22 antibody, 17-7222-80, Invitrogen Antibodies. Intracellular staining of 7-day Th17-polarized CD4+ normal human peripheral blood cells (using Human IL-23 Recombinant Protein (Product # 14-8239-63) (left) and 12-day Th17-polarized mouse splenocytes (using Mouse IL-23 Recombinant Protein (Product # 14-8231-63) (right) with 0.125 µg of Anti-Human/Mouse IL-22 APC. Both sets of polarized cells were incubated with PMA, Ionomycin, and Brefeldin A for 5 hours prior to treatment with the Intracellular Fixation & Permeabilization Buffer Set (Pro

Rat Mono [IL22JOP], 25 ug
Hu, Mo, Pr
FACS

Supplier data
Invitrogen Antibodies 25-7229-41

Interleukin 22 antibody, 25-7229-41, Invitrogen Antibodies. Intracellular staining of CD4-enriched Th17-polarized (using Human IL-23 Recombinant Protein (Product # 14-8239-63), normal human peripheral blood cells with Anti-Human CD4 FITC (Product # 11-0049-42) and Anti-Human IL-22 PE-Cyanine7. Cultures were treated with Protein Transport Inhibitor Cocktail alone (Product # 00-4980-03) (left) or Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right) for 5 hours prior to intracellular staining using the Intracellular F

Mouse Mono [22URTI], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 48-7229-42

Interleukin 22 antibody, 48-7229-42, Invitrogen Antibodies. CD4-enriched normal human peripheral blood cells were polarized under Th17 conditions for 10 days then treated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) or Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right) for 5 hours. Cells were fixed and permeabilized with the Fixation & Permeabilization Buffers (Product # 00-8823) and then intracellularly stained with Anti-Human CD4 APC (Product # 17-0049-42) and Anti-Human IL-22 eFluor&

Mouse Mono [22URTI], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 17-7222-82

Interleukin 22 antibody, 17-7222-82, Invitrogen Antibodies. Intracellular staining of 7-day Th17-polarized CD4+ normal human peripheral blood cells (using Human IL-23 Recombinant Protein (Product # 14-8239-63) (left) and 12-day Th17-polarized mouse splenocytes (using Mouse IL-23 Recombinant Protein (Product # 14-8231-63) (right) with 0.125 µg of Anti-Human/Mouse IL-22 APC. Both sets of polarized cells were incubated with PMA, Ionomycin, and Brefeldin A for 5 hours prior to treatment with the Intracellular Fixation & Permeabilization Buffer Set (Pro

Rat Mono [IL22JOP], 100 ug
Hu, Mo, Pr
FACS

Supplier data
Invitrogen Antibodies 12-7221-82

Interleukin 22 antibody, 12-7221-82, Invitrogen Antibodies. Staining of 11-day Th17-polarized mouse splenocytes with Anti-Mouse CD4 FITC (Product # 11-0042-82) and 0.06 µg of Anti-Mouse IL-22 PE. Cells were treated with Brefeldin A (Product # 00-4506-51) alone (left) or PMA, Ionomycin, and Brefeldin A (right) for 5 hours prior to intracellular staining. Cells in the lymphocyte gate were used for analysis.

Rat Mono [1H8PWSR], 100 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 48-7229-41

Interleukin 22 antibody, 48-7229-41, Invitrogen Antibodies. CD4-enriched normal human peripheral blood cells were polarized under Th17 conditions for 10 days then treated with Protein Transport Inhibitor Cocktail (Product # 00-4980-03) (left) or Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right) for 5 hours. Cells were fixed and permeabilized with the Fixation & Permeabilization Buffers (Product # 00-8823) and then intracellularly stained with Anti-Human CD4 APC (Product # 17-0049-42) and Anti-Human IL-22 eFluor&

Mouse Mono [22URTI], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 46-7229-41

Interleukin 22 antibody, 46-7229-41, Invitrogen Antibodies. Intracellular staining of Th17-polarized normal human peripheral blood cells treated with Brefeldin A (Product # 00-4506-51) (left) or restimulated with PMA/Ionomycin in the presence of Brefeldin A (right) with Anti-Human IL-17F PE (Product # 12-7169-42) and Anti-Human IL-22 PerCP-eFluor® 710. Cells in the lymphocyte gate were used for analysis.

Mouse Mono [22URTI], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 11-7229-42

Interleukin 22 antibody, 11-7229-42, Invitrogen Antibodies. Intracellular staining of CD4-enriched Th17-polarized (using Human IL-23 Recombinant Protein (Product # 14-8239-63), normal human peripheral blood cells with Anti-Human CD4 eFluor® 450 (Product # 48-0049-42) and Anti-Human IL-22 FITC. Cultures were treated with Protein Transport Inhibitor Cocktail (500X) (Product # 00-4980-03) alone (left) or Cell Stimulation Cocktail (plus protein transport inhibitors) (500X) (Product # 00-4975-03) (right) for 5 hours prior to intracellular staining using t

Mouse Mono [22URTI], 100 Test
Hu
FACS

Western Blot

Supplier data
Origene TA337159 Interleukin 22 antibody, TA337159, Origene.

Mouse Mono [8F11E2], 100 ug
Hu
FACS, IHC-P, WB

FACS, IHC-P

Supplier data
Boster Biological Technology M00963 Interleukin 22 antibody, M00963, Boster Biological Technology. Figure 2. Western blot analysis of IL22 using anti-IL22 antibody (M00963). <br> Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 50ug of sample under reducing conditions. <br> Lane 1: human U-87MG whole cell lysates

Interleukin 22 antibody, M00963, Boster Biological Technology. Figure 2. Western blot analysis of IL22 using anti-IL22 antibody (M00963). <br> Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 50ug of sample under reducing conditions. <br> Lane 1: human U-87MG whole cell lysates

Mouse Mono [M00963], 100 ug
Hu
FACS, WB

Interleukin 22 antibody, M00963, Boster Biological Technology, Flow Cytometry image

FACS

Supplier data
Novus Biologicals NBP2-27339 Interleukin 22 antibody, NBP2-27339, Novus Biologicals. Western Blot: IL-22 Antibody (8F11E2) [NBP2-27339] - Analysis of IL-22 in A) recombinant protein and B) human spleen lysate using IL-22 antibody at 1 ug/ml. I goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.

Interleukin 22 antibody, NBP2-27339, Novus Biologicals. Western Blot: IL-22 Antibody (8F11E2) [NBP2-27339] - Analysis of IL-22 in A) recombinant protein and B) human spleen lysate using IL-22 antibody at 1 ug/ml. I goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.

Mouse Mono [8F11E2], 100 ug
Hu
IHC-F, IHC-P, WB

Interleukin 22 antibody, NBP2-27339, Novus Biologicals, Immunohistochemistry frozen image

IHC-F,

Interleukin 22 antibody, NBP2-27339, Novus Biologicals, Immunohistochemistry paraffin image

IHC-P

Supplier data
Novus Biologicals NBP2-27322 Interleukin 22 antibody, NBP2-27322, Novus Biologicals. Western Blot: IL-22 Antibody (8F6F10) [NBP2-27322] - Analysis of IL-22 in recombinant protein using IL-22 antibody at2 ug/ml.

Interleukin 22 antibody, NBP2-27322, Novus Biologicals. Western Blot: IL-22 Antibody (8F6F10) [NBP2-27322] - Analysis of IL-22 in recombinant protein using IL-22 antibody at2 ug/ml.

Mouse Mono [8F6F10], 100 ug
Hu
WB

Supplier data
R&D Systems MAB582

Interleukin 22 antibody, MAB582, R&D Systems. Detection of IL-22 in EL-4 Mouse Cell Line by Flow Cytometry. EL-4 mouse lymphoblast cell line was stained with Rat Anti-Mouse IL-22 Monoclonal Antibody (Catalog # MAB582, dark orange histogram) or isotype control antibody (Catalog # <a class=NoLineLink href='http://www.rndsystems.com/search?keywords=MAB006'>MAB006</a>, open histogram), followed by Phycoerythrin-conjugated Anti-Rat IgG F(ab')2 Secondary Antibody (Catalog # <a class=NoLineLink href="http://www.rndsystems.com/search?keywords=F0105

Rat Mono [140301], 500 ug
Mo
FACS, WB

Interleukin 22 antibody, MAB582, R&D Systems, Flow Cytometry image

FACS

Supplier data
Abcam ab134035 Interleukin 22 antibody, ab134035, Abcam.

Mouse Mono [IMG8F11E2], 100 ug
Hu
WB

Supplier data
BioLegend 517501 Interleukin 22 antibody, 517501, BioLegend. 20 ng recombinant mouse Il-22 protein wa separated by electrophoresis, transferred to nitrocellulose, and probed with monoclonal mIL-22 antibody (BL35175). Protein was visualized using a goat anti-rat IgG secondary conjugated to HRP and chemiluminescence detection.

Interleukin 22 antibody, 517501, BioLegend. 20 ng recombinant mouse Il-22 protein wa separated by electrophoresis, transferred to nitrocellulose, and probed with monoclonal mIL-22 antibody (BL35175). Protein was visualized using a goat anti-rat IgG secondary conjugated to HRP and chemiluminescence detection.

Rat Mono [BL35175], 25 ug
Mo
WB

Supplier data
BioLegend 517502 Interleukin 22 antibody, 517502, BioLegend. 20 ng recombinant mouse Il-22 protein wa separated by electrophoresis, transferred to nitrocellulose, and probed with monoclonal mIL-22 antibody (BL35175). Protein was visualized using a goat anti-rat IgG secondary conjugated to HRP and chemiluminescence detection.

Interleukin 22 antibody, 517502, BioLegend. 20 ng recombinant mouse Il-22 protein wa separated by electrophoresis, transferred to nitrocellulose, and probed with monoclonal mIL-22 antibody (BL35175). Protein was visualized using a goat anti-rat IgG secondary conjugated to HRP and chemiluminescence detection.

Rat Mono [BL35175], 100 ug
Mo
WB

Related antibodies

Interleukin 22 antibodies are often published with	Associated citations
IL-17	24.1%
IL-12	18.8%
CD3	13.2%
IL-4	10.2%
IL-6	6.4%
CD8	6.4%
PMP-22	6.4%
His tag	6.0%
CD44	6.0%
c-Kit	5.6%

Bac	Bacteria
Bt	Bat
Bv	Bovine
Cel	C.Elegans
Cml	Camel
Cn	Canine
chem	Chemical
Ch	Chicken
Dk	Donkey
Dr	Drosophila
Du	Duck
Eq	Equine
Eu	Eukaryotes
Fe	Feline
Fi	Fish
Fr	Frog
Fu	Fungus
Gt	Goat
Gf	Goldfish
GP	Guinea Pig
Ha	Hamster
Hu	Human
Inv	Invertebrates
Llm	Llama
Mam	Mammals
Mo	Mouse
Pl	Plant
Po	Porcine
Pr	Primate
Pro	Prokaryotes
Rb	Rabbit
Rt	Rat
Sh	Sheep
Sq	Squirrel
Vert	Vertebrates
Vi	Virus
Xe	Xenopus
Yt	Yeast
Zf	Zebrafish

AP	Affinity purification
Bl	Blocking
ChIP	Chromatin Immunoprecipitation
DB	Dot Blot
EMSA	Electron Microscopy
ELISA	Enzyme Linked Immunosorbent Assay
FACS	Flow Cytometry
FA	Functional Assay
GS	Gel Shift
ICC	Immunocytochemistry
ID	Immunodiffusion
IF	Immunofluorescence
IHC-F	Immunohistochemistry frozen
IHC-P	Immunohistochemistry paraffin
IP	Immunoprecipitation
IVT	In vivo targeting
Neu	Neutralising
Pep-ELISA	Peptide ELISA
PLA	Proximity Ligation Assay
RIA	Radioimmunoassay
WB	Western Blot

179 matching Interleukin 22 monoclonal antibodies from 14 suppliers

Superstar Kits

Interleukin 22 information

Aliases

7 Applications, 4 Species currently selected